Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo

J Invest Dermatol. 2022 Dec;142(12):3352-3355.e4. doi: 10.1016/j.jid.2022.05.1093. Epub 2022 Jul 1.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Hypopigmentation*
  • Nitriles
  • Phototherapy
  • Pyrazoles / therapeutic use
  • Pyrimidines
  • Treatment Outcome
  • Ultraviolet Therapy*
  • Vitiligo* / drug therapy

Substances

  • Pyrazoles
  • ruxolitinib
  • Nitriles
  • Pyrimidines